Eupraxia Pharmaceuticals, Inc. · TSX:EPRX

Joseph S. Freedman reported a 10.20% stake in Eupraxia Pharmaceuticals, Inc. (Schedule 13D/A)

Event Sep 24, 2025 · Filed Sep 26, 2025

Joseph S. Freedman reported a 10.20% stake in Eupraxia Pharmaceuticals, Inc., 5,533,215 shares, with active intent on Sep 24, 2025. Filed Sep 26, 2025 (Schedule 13D/A).

Stake
10.20%
Shares
5,533,215
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Joseph S. Freedman10.20%5,533,215

Source

View original at SEC

Related